{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T15:52:03Z","timestamp":1784130723430,"version":"3.55.0"},"reference-count":49,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2020,3,16]],"date-time":"2020-03-16T00:00:00Z","timestamp":1584316800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxins"],"abstract":"<jats:p>Diabetes mellitus (DM) is an independent risk factor for overactive bladder (OAB). The pathophysiology of DM-associated OAB is multifactorial and time-dependent. Diabetic bladder dysfunction is highly associated with diabetic complications, mainly including diabetic neuropathy and atherosclerosis. Chronic systemic inflammation and bladder urothelial inflammation may contribute to the onset of OAB. Intravesical botulinum toxin A (BoNT-A) injection has proved to be a successful treatment for idiopathic and neurogenic OAB. BoNT-A can inhibit the efferent pathways of the bladder as well as the chronic inflammation and hypersensitivity via the afferent pathways. We conducted a review of the published literature in Pubmed using a combination of two keywords, namely \u201cbotulinum toxin A\u201d (BoNT-A) and \u201coveractive bladder\u201d, with or without the additional keywords \u201cdetrusor overactivity\u201d, \u201cdiabetes mellitus\u201d, \u201cinflammation\u201d, and \u201curodynamic study\u201d. We also reviewed the experience of our research teams, who have published several studies of the association between DM and OAB. Since limited data support the effectiveness and safety of BoNT-A for treating patients with DM-associated OAB, a comprehensive evaluation of diabetic complications and urodynamic study is needed before treatment. In the future, it is imperative to explore the clinical characteristics and inflammatory biomarkers of diabetes as determining predictors of the treatment efficacy.<\/jats:p>","DOI":"10.3390\/toxins12030186","type":"journal-article","created":{"date-parts":[[2020,3,20]],"date-time":"2020-03-20T07:29:07Z","timestamp":1584689347000},"page":"186","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["The Pharmacological Mechanism of Diabetes Mellitus-Associated Overactive Bladder and Its Treatment with Botulinum Toxin A"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2629-4011","authenticated-orcid":false,"given":"Chung-Cheng","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Urology, En Chu Kong Hospital, New Taipei City 23702, Taiwan"},{"name":"Department of Biomedical Engineering, Chung Yuan Christian University, Taoyuan City 32023, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yung-Hong","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Urology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation and Tzu Chi University, Hualien 97002, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7165-4771","authenticated-orcid":false,"given":"Hann-Chorng","family":"Kuo","sequence":"additional","affiliation":[{"name":"Department of Urology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation and Tzu Chi University, Hualien 97002, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,3,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Xu, D., Zhao, M., Huang, L., and Wang, K. (2018). Overactive bladder symptom severity, bother, help-seeking behavior, and quality of life in patients with type 2 diabetes: A path analysis. Health Qual. Life Outcomes, 16.","DOI":"10.1186\/s12955-017-0829-z"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/01.AOG.0000133482.20685.d1","article-title":"Urinary incontinence in elderly women: Findings from the Health, Aging, and Body Composition Study","volume":"104","author":"Jackson","year":"2004","journal-title":"Obstet. Gynecol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/nau.10067","article-title":"Prevalence and correlations of anal incontinence and constipation in Taiwanese women","volume":"22","author":"Chen","year":"2003","journal-title":"Neurourol. Urodyn."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1111\/j.1442-2042.2012.03095.x","article-title":"Higher glycosylated hemoglobin levels increase the risk of overactive bladder syndrome in patients with type 2 diabetes mellitus","volume":"19","author":"Chiu","year":"2012","journal-title":"Int. J. Urol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1111\/j.1464-410X.2009.08913.x","article-title":"Type 2 diabetes but not metabolic syndrome is associated with an increased risk of lower urinary tract symptoms and erectile dysfunction in men aged <45 years","volume":"105","author":"Wang","year":"2010","journal-title":"BJU Int."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1111\/j.1742-1241.2012.03009.x","article-title":"Comparative persistence and adherence to overactive bladder medications in patients with and without diabetes","volume":"66","author":"Johnston","year":"2012","journal-title":"Int. J. Clin. Pract."},{"key":"ref_7","first-page":"291","article-title":"Diabetic cystopathy. IV: Micturition cystourethrography compared with urodynamic investigation","volume":"23","author":"Moller","year":"1976","journal-title":"Dan. Med. Bull."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"552","DOI":"10.4103\/2230-8210.137518","article-title":"A study of bladder dysfunction in women with type 2 diabetes mellitus","volume":"18","author":"Karoli","year":"2014","journal-title":"Indian J. Endocrinol. Metab."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/iju.13935","article-title":"Urodynamic analysis of the impact of diabetes mellitus on bladder function","volume":"26","author":"Majima","year":"2019","journal-title":"Int. J. Urol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.urology.2010.04.062","article-title":"Urodynamic profile of diabetic patients with lower urinary tract symptoms: Association of diabetic cystopathy with autonomic and peripheral neuropathy","volume":"77","author":"Bansal","year":"2011","journal-title":"Urology"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.juro.2008.09.021","article-title":"Investigation of urodynamic characteristics and bladder sensory function in the early stages of diabetic bladder dysfunction in women with type 2 diabetes","volume":"181","author":"Lee","year":"2009","journal-title":"J. Urol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/luts.12102","article-title":"Correlation between advanced glycation end-products, lower urinary tract symptoms and bladder dysfunctions in patients with type 2 diabetes mellitus","volume":"9","author":"Gali","year":"2017","journal-title":"Low. Urin. Tract. Symptoms"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/nau.20727","article-title":"Urodynamic findings in female diabetic patients with and without overactive bladder symptoms","volume":"29","author":"Ho","year":"2010","journal-title":"Neurourol. Urodyn."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/j.1464-410X.2005.05392.x","article-title":"Recent advances in understanding the biology of diabetes-associated bladder complications and novel therapy","volume":"95","author":"Yoshimura","year":"2005","journal-title":"BJU Int."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0304-3940(99)00871-X","article-title":"Alterations in urinary bladder M2-muscarinic receptor protein and mRNA in 2-week streptozotocin-induced diabetic rats","volume":"277","author":"Tong","year":"1999","journal-title":"Neurosci. Lett."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1159\/000056164","article-title":"Alteration of M(3) subtype muscarinic receptors in the diabetic rat urinary bladder","volume":"64","author":"Tong","year":"2002","journal-title":"Pharmacology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"F388","DOI":"10.1152\/ajprenal.00178.2019","article-title":"Detrusor contractility to parasympathetic mediators is differentially altered in the compensated and decompensated states of diabetic bladder dysfunction","volume":"317","author":"Klee","year":"2019","journal-title":"Am. J. Physiol. Renal. Physiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.urology.2007.11.054","article-title":"Time-dependent alterations of select genes in streptozotocin-induced diabetic rat bladder","volume":"71","author":"Gray","year":"2008","journal-title":"Urology"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.urology.2008.11.026","article-title":"Diabetes-induced alternations in biomechanical properties of urinary bladder wall in rats","volume":"73","author":"Wang","year":"2009","journal-title":"Urology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"232","DOI":"10.5213\/inj.1632508.254","article-title":"Association Between Overactive Bladder and Polyneuropathy in Diabetic Patients","volume":"20","author":"Tanik","year":"2016","journal-title":"Int. Neurourol. J."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Lee, W.C., Wu, H.C., Huang, K.H., Wu, H.P., Yu, H.J., and Wu, C.C. (2014). Hyposensitivity of C-fiber afferents at the distal extremities as an indicator of early stages diabetic bladder dysfunction in type 2 diabetic women. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0086463"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"R84","DOI":"10.1152\/ajpregu.00129.2012","article-title":"Impact of diabetes mellitus on bladder uroepithelial cells","volume":"304","author":"Ruiz","year":"2013","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/luts.12126","article-title":"Urothelial Dysfunction and Chronic Inflammation in Diabetic Patients with Overactive Bladder","volume":"9","author":"Wang","year":"2017","journal-title":"Low. Urin. Tract. Symptoms"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/nri2925","article-title":"Type 2 diabetes as an inflammatory disease","volume":"11","author":"Donath","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.diabres.2014.04.006","article-title":"Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes","volume":"105","author":"Esser","year":"2014","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.atherosclerosis.2016.04.015","article-title":"Inflammation biomarkers and mortality prediction in patients with type 2 diabetes (ZODIAC-27)","volume":"250","author":"Landman","year":"2016","journal-title":"Atherosclerosis"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.3889\/oamjms.2019.646","article-title":"Role of Inflammation in the Pathogenesis of Diabetic Peripheral Neuropathy","volume":"7","author":"Papazova","year":"2019","journal-title":"Open Access Maced. J. Med. Sci."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.cyto.2018.10.007","article-title":"Decreased plasma neuregulin 4 levels are associated with peripheral neuropathy in Chinese patients with newly diagnosed type 2 diabetes: A cross-sectional study","volume":"113","author":"Yan","year":"2019","journal-title":"Cytokine"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1002\/nau.23452","article-title":"Is overactive bladder microvasculature disease a component of systemic atheroscleorosis?","volume":"37","author":"Yeniel","year":"2018","journal-title":"Neurourol. Urodyn."},{"key":"ref_30","first-page":"219","article-title":"Diabetic bladder dysfunction is associated with bladder inflammation triggered through hyperglycemia, not polyuria","volume":"10","author":"Inouye","year":"2018","journal-title":"Res. Rep. Urol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.juro.2012.08.222","article-title":"Roles of polyuria and hyperglycemia in bladder dysfunction in diabetes","volume":"189","author":"Xiao","year":"2013","journal-title":"J. Urol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"430","DOI":"10.2337\/db18-0845","article-title":"NLRP3 promotes diabetic bladder dysfunction and changes in symptom-specific bladder innervation","volume":"68","author":"Hughes","year":"2019","journal-title":"Diabetes"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"F113","DOI":"10.1152\/ajprenal.00400.2018","article-title":"Bladder decompensation and reduction in nerve density in a rat model of chronic bladder outlet obstruction are attenuated with the NLRP3 inhibitor glyburide","volume":"316","author":"Hughes","year":"2019","journal-title":"Am. J. Physiol. Renal. Physiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"3754","DOI":"10.2337\/db16-0480","article-title":"Toll-like receptor 4 activation contributes to diabetic bladder dysfunction in a murine model of type 1 diabetes","volume":"65","author":"Szasz","year":"2016","journal-title":"Diabetes"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1442-2042.2012.03035.x","article-title":"Botulinum toxin injection for lower urinary tract dysfunction","volume":"20","author":"Kuo","year":"2013","journal-title":"Int. J. Urol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.urology.2003.12.007","article-title":"Urodynamic evidence of effectiveness of botulinum A toxin injection in treatment of detrusor overactivity refractory to anticholinergic agents","volume":"63","author":"Kuo","year":"2004","journal-title":"Urology"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Jhang, J.F., and Kuo, H.C. (2016). Botulinum toxin A and lower urinary tract dysfunction: Pathophysiology and mechanisms of action. Toxins, 8.","DOI":"10.3390\/toxins8040120"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1113\/jphysiol.2012.242131","article-title":"Transsynaptic inhibition of spinal transmission by A2 botulinum toxin","volume":"591","author":"Akaike","year":"2013","journal-title":"J. Physiol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/bju.13163","article-title":"Retrograde transport of radiolabelled botulinum neurotoxin type A to the CNS after intradetrusor injection in rats","volume":"117","author":"Papagiannopoulou","year":"2016","journal-title":"BJU Int."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1464-410X.2007.07312.x","article-title":"Botulinum toxin type A inhibits sensory neuropeptide release in rat bladder models of acute injury and chronic inflammation","volume":"101","author":"Lucioni","year":"2008","journal-title":"BJU Int."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.neuint.2007.11.006","article-title":"Botulinum toxin type A normalizes alterations in urothelial ATP and NO release induced by chronic spinal cord injury","volume":"52","author":"Smith","year":"2008","journal-title":"Neurochem. Int."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Ha, U.S., Park, E.Y., and Kim, J.C. (2011). Effect of botulinum toxin on expression of nerve growth factor and transient receptor potential vanilloid 1 in urothelium and detrusor muscle of rats with bladder outlet obstruction-induced detrusor overactivity. Urology, 78.","DOI":"10.1016\/j.urology.2011.03.070"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.urology.2012.12.021","article-title":"Botulinum toxin A detrusor injections reduce postsynaptic muscular M2, M3, P2X2, and P2X3 receptors in children and adolescents who have neurogenic detrusor overactivity: A single-blind study","volume":"81","author":"Priefert","year":"2013","journal-title":"Urology"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1002\/nau.23207","article-title":"The effect of intradetrusor botulinum neurotoxin type A on urinary NGF, TGF BETA-1, TIMP-2 levels in children with neurogenic detrusor overactivity due to myelodysplasia","volume":"36","author":"Top","year":"2017","journal-title":"Neurourol. Urodyn."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1002\/nau.22494","article-title":"Diabetes mellitus does not affect the efficacy and safety of intravesical onabotulinumtoxina injection in patients with refractory detrusor overactivity","volume":"33","author":"Wang","year":"2014","journal-title":"Neurourol. Urodyn."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/j.juro.2009.08.070","article-title":"Diabetic bladder dysfunction: Current translational knowledge","volume":"182","author":"Daneshgari","year":"2009","journal-title":"J. Urol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1007\/s11255-014-0778-y","article-title":"The overactive bladder progression to underactive bladder hypothesis","volume":"46","author":"Chancellor","year":"2014","journal-title":"Int. Urol. Nephrol."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Wang, C.C., Lee, C.L., and Kuo, H.C. (2016). Efficacy and Safety of Intravesical OnabotulinumtoxinA Injection in Patients with Detrusor Hyperactivity and Impaired Contractility. Toxins, 8.","DOI":"10.3390\/toxins8030082"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.eururo.2010.09.007","article-title":"Adverse events of intravesical botulinum toxin a injections for idiopathic detrusor overactivity: Risk factors and influence on treatment outcome","volume":"58","author":"Kuo","year":"2010","journal-title":"Eur. Urol."}],"container-title":["Toxins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6651\/12\/3\/186\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:07:14Z","timestamp":1760173634000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6651\/12\/3\/186"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,16]]},"references-count":49,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,3]]}},"alternative-id":["toxins12030186"],"URL":"https:\/\/doi.org\/10.3390\/toxins12030186","relation":{},"ISSN":["2072-6651"],"issn-type":[{"value":"2072-6651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,16]]}}}